Home Data Calendar Blog

MEDP

Tables

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Common Stock Value		0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.34	0.36	0.36	0.36	0.36	0.35	0.36	0.35	0.35	0.36	0.36	0.36	0.36	0.36	0.36	0.36	0.35	0.35	0.38	0.40	0.41	0.41	0.41	NA	NA	0.33	NA
Weighted Average Number Of Diluted Shares Outstanding		32.00	NA	31.76	31.57	32.16	NA	32.25	33.70	36.36	NA	37.52	37.71	37.75	NA	37.76	37.33	38.03	NA	37.84	37.39	37.28	NA	37.12	36.66	36.45	NA	39.33	40.83	41.51	NA	37.62	32.83	32.62	NA	31.43
Weighted Average Number Of Shares Outstanding Basic		30.84	NA	30.63	30.54	31.01	NA	31.01	32.49	34.92	NA	35.82	35.89	35.75	NA	35.55	35.39	36.02	NA	35.94	35.84	35.70	NA	35.57	35.52	35.49	NA	38.58	40.18	40.67	NA	37.12	32.64	32.62	NA	31.43
Earnings Per Share Basic		3.32	2.55	2.30	2.00	2.35	2.18	2.13	1.52	1.75	1.39	1.35	1.11	1.21	1.43	1.16	0.68	0.80	0.82	0.67	0.76	0.54	0.64	0.54	0.46	0.41	0.30	0.25	0.24	0.21	0.00	0.14	0.15	0.11	-0.27	0.00
Earnings Per Share Diluted		3.20	2.46	2.22	1.93	2.27	2.10	2.05	1.46	1.69	1.32	1.29	1.06	1.14	1.34	1.09	0.64	0.76	0.78	0.63	0.73	0.51	0.61	0.52	0.45	0.40	0.30	0.25	0.23	0.20	0.00	0.13	0.15	0.11	-0.27	0.00

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Revenue From Contract With Customer Excluding Assessed Tax		511.04	498.40	492.50	460.87	434.07	394.10	383.74	351.21	330.95	308.55	295.57	278.29	259.96	259.68	230.37	205.00	230.88	229.89	216.24	214.10	200.74	192.12	179.25	170.14	163.08	112.68	110.64	106.22	106.61	108.24	107.80	105.95	99.59	96.04	92.13
Revenues		511.04	498.40	492.50	460.87	434.07	394.10	383.74	351.21	330.95	308.55	295.57	278.29	259.96	259.68	230.37	205.00	230.88	229.89	216.24	214.10	200.74	192.12	179.25	170.14	163.08	112.68	110.64	106.22	0.00	108.24	107.80	105.95	99.59	96.04	92.13
Costs And Expenses		406.98	411.08	407.59	382.48	347.87	317.67	305.92	290.97	266.74	253.70	241.85	235.84	212.37	204.69	183.95	174.87	195.38	193.77	186.25	178.84	174.85	161.45	152.34	146.80	142.96	97.25	93.44	89.94	90.67	95.35	95.18	91.84	86.72	96.93	84.94
Selling General And Administrative Expense		44.08	42.51	41.41	39.40	38.03	33.40	35.42	33.22	29.37	27.66	28.05	26.97	25.74	22.38	22.80	21.86	25.12	21.26	29.12	23.56	21.31	20.57	18.61	20.51	16.00	16.84	16.61	14.76	15.15	16.78	16.39	14.82	13.51	18.25	15.29
Operating Income Loss		104.07	87.32	84.91	78.39	86.20	76.43	77.83	60.24	64.20	54.85	53.71	42.45	47.60	54.99	46.42	30.13	35.50	36.12	29.99	35.26	25.89	30.67	26.92	23.34	20.12	15.44	17.20	16.28	15.94	12.89	12.62	14.11	12.87	-0.89	7.20
Interest Income Expense Nonoperating Net		4.12	1.84	-0.10	-1.37	-0.86	-0.83	-1.58	-0.55	0.05	-0.02	-0.04	-0.03	-0.01	-0.03	-0.02	-0.01	0.36	0.39	-0.25	-0.75	-0.95	-1.60	-1.94	-2.31	-2.31	-2.05	-1.91	-1.81	-1.79	-2.83	-4.66	-5.92	-5.97	-6.55	-6.74
Income Tax Expense Benefit		10.19	12.41	12.65	14.68	13.14	4.97	15.87	12.64	4.01	5.89	6.16	2.75	5.20	3.84	5.53	6.26	7.52	6.40	5.49	7.04	5.46	6.56	6.15	4.95	3.11	2.38	5.32	4.79	5.33	0.25	2.55	3.23	2.51	0.94	0.64
Net Income Loss		102.59	78.30	70.55	61.07	72.89	68.67	66.03	49.36	61.31	50.03	48.57	39.93	43.31	50.87	41.46	24.10	28.95	29.81	23.98	27.45	19.20	22.76	19.30	16.57	14.55	11.29	9.83	9.55	8.45	-0.02	5.04	4.96	3.45	-8.58	-0.13
Comprehensive Income Net Of Tax		100.62	81.10	68.87	61.19	73.97	72.33	59.95	45.78	59.77	48.43	47.09	40.44	41.17	52.86	42.56	24.61	27.97	30.73	22.69	27.87	18.92	22.42	19.24	14.56	15.18	11.82	10.60	10.67	9.04	-1.39	5.21	4.40	4.02	-9.05	-0.26
Net Income Loss Available To Common Stockholders Basic		102.55	78.25	70.50	61.03	72.84	68.62	65.98	49.33	61.27	49.99	48.42	39.81	43.17	50.66	41.33	24.04	28.88	29.73	23.91	27.38	19.14	22.67	19.23	16.50	14.49	11.24	9.81	9.54	8.44	-0.05	5.04	4.96	3.45	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Assets		1795.79	1656.83	1486.72	1406.94	1395.72	1352.49	1328.42	1315.45	1344.35	1659.93	1577.14	1469.71	1451.36	1390.68	1296.14	1222.13	1137.63	1143.07	1072.33	1016.86	1006.52	967.93	949.84	968.18	973.02	950.72	948.88	963.65	966.09	979.11	976.49	NA	NA	984.04	NA
Liabilities		1124.25	1097.88	1015.81	1015.88	1048.46	966.11	978.54	1032.20	739.33	707.01	679.06	617.83	592.43	584.90	504.51	484.06	419.83	416.79	380.32	358.81	384.62	378.23	388.45	428.10	461.95	447.19	398.63	356.29	345.11	368.39	365.95	NA	NA	570.57	NA
Liabilities And Stockholders Equity		1795.79	1656.83	1486.72	1406.94	1395.72	1352.49	1328.42	1315.45	1344.35	1659.93	1577.14	1469.71	1451.36	1390.68	1296.14	1222.13	1137.63	1143.07	1072.33	1016.86	1006.52	967.93	949.84	968.18	973.02	950.72	948.88	963.65	966.09	979.11	976.49	NA	NA	984.04	NA
Stockholders Equity		671.54	558.95	470.91	391.06	347.26	386.39	349.88	283.25	605.02	952.93	898.09	851.88	858.93	805.78	791.63	738.07	717.80	726.28	692.01	658.05	621.90	589.70	561.39	540.08	511.07	503.53	550.25	607.36	620.98	610.71	610.54	NA	NA	413.47	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Assets Current		744.90	593.83	448.88	378.93	367.62	333.96	337.74	328.89	355.97	690.91	641.22	550.10	533.38	473.65	395.00	319.08	303.00	317.03	250.40	194.34	182.38	178.11	153.09	158.48	153.75	129.97	117.03	123.12	128.32	133.25	120.53	NA	NA	94.72	NA
Cash And Cash Equivalents At Carrying Value		407.01	245.45	95.21	39.14	46.92	28.27	31.01	42.55	82.84	461.30	398.39	339.01	332.88	277.77	219.23	160.90	134.00	131.92	79.29	20.10	30.13	23.27	22.24	22.23	22.25	26.48	24.17	29.05	29.32	37.10	14.64	NA	NA	14.88	40.63
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents		407.01	245.45	95.21	39.14	46.92	28.27	31.01	42.55	82.84	461.30	398.39	339.01	332.88	277.77	219.23	160.90	134.00	131.92	79.29	20.10	30.13	23.28	22.25	22.24	22.25	26.49	24.25	29.33	29.61	37.41	18.00	17.04	NA	17.74	NA
Receivables Net Current		279.17	298.40	292.77	275.06	257.75	253.40	249.09	225.69	224.76	186.43	186.38	161.49	160.00	160.96	134.09	127.29	136.37	155.66	140.19	149.86	129.62	133.45	108.28	115.40	110.65	83.08	74.71	76.66	82.28	79.77	81.92	NA	NA	65.09	NA
Prepaid Expense And Other Assets Current		58.73	49.98	60.90	64.73	62.95	52.29	57.65	60.64	48.37	43.18	56.45	49.60	40.51	34.92	41.69	30.89	32.63	29.45	30.92	24.39	22.62	21.38	22.55	20.84	20.85	20.40	18.07	17.13	16.43	16.07	20.61	NA	NA	11.90	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Property Plant And Equipment Gross		NA	199.99	NA	NA	NA	171.97	NA	NA	NA	144.25	NA	NA	NA	124.12	NA	NA	NA	78.92	NA	NA	NA	85.37	NA	NA	NA	74.86	NA	NA	NA	61.43	NA	NA	NA	48.19	NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment		NA	79.40	NA	NA	NA	62.12	NA	NA	NA	51.10	NA	NA	NA	39.11	NA	NA	NA	31.63	NA	NA	NA	33.11	NA	NA	NA	26.12	NA	NA	NA	17.63	NA	NA	NA	10.67	NA
Amortization Of Intangible Assets		0.36	0.55	0.55	0.55	0.55	0.84	0.84	0.84	0.84	1.28	1.28	1.28	1.28	1.95	1.95	1.98	2.00	3.00	3.00	3.00	5.84	7.39	7.39	7.39	7.39	9.49	9.50	9.46	9.45	12.67	12.67	12.67	12.67	13.12	15.77
Property Plant And Equipment Net		118.60	120.59	114.76	114.82	113.75	109.85	104.72	103.54	98.53	93.15	87.70	86.19	84.50	85.02	71.47	65.95	50.02	47.29	43.72	39.75	37.64	52.26	52.03	52.36	51.08	48.74	45.90	45.24	44.98	43.80	41.34	NA	NA	37.51	NA
Goodwill		662.40	662.40	662.40	662.40	662.40	662.40	662.40	662.40	662.40	662.40	662.40	662.40	662.40	662.40	662.46	662.43	662.43	662.40	662.43	662.43	662.38	660.98	660.98	660.98	660.98	660.98	660.98	660.98	660.98	660.98	660.98	NA	NA	660.98	NA
Intangible Assets Net Excluding Goodwill		35.45	35.81	36.36	36.91	37.46	38.01	38.85	39.68	40.52	41.36	42.64	43.92	45.20	46.47	48.42	50.37	52.35	54.35	57.34	60.34	63.34	69.18	76.57	83.96	91.35	98.74	108.23	117.68	126.62	136.07	148.74	NA	NA	186.74	NA
Finite Lived Intangible Assets Net		3.80	4.16	4.71	5.26	5.81	6.36	7.20	8.04	8.88	9.71	10.99	12.27	13.55	14.83	16.78	18.73	20.71	22.70	25.70	28.69	31.69	37.53	44.92	52.31	59.70	67.09	76.59	86.03	94.98	104.42	117.09	NA	NA	155.10	NA
Other Assets Noncurrent		20.41	24.97	20.83	22.26	22.03	21.13	18.63	19.12	19.48	17.42	16.48	15.83	13.06	8.79	8.77	10.26	10.68	9.48	5.67	7.88	6.83	6.69	6.73	6.43	5.89	5.94	5.61	5.09	5.03	4.90	4.76	NA	NA	3.93	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Liabilities Current		956.64	925.13	848.52	852.44	881.89	803.47	820.87	878.96	579.43	557.22	517.18	472.61	447.31	440.11	358.40	337.98	338.65	343.00	314.39	296.07	264.54	257.03	232.13	233.16	232.49	192.71	172.36	155.26	150.04	168.60	156.59	NA	NA	134.02	NA
Accounts Payable Current		24.40	31.87	29.02	33.61	37.11	33.07	28.25	28.80	25.43	25.68	25.05	23.33	21.35	26.55	15.88	14.88	16.98	22.40	20.68	22.69	13.63	16.74	13.60	16.86	17.92	16.67	9.97	7.20	8.35	10.91	9.34	NA	NA	8.73	NA
Other Accrued Liabilities Current		13.66	11.28	11.28	9.75	11.55	10.51	13.00	11.59	9.27	9.60	10.14	9.21	8.56	7.07	6.03	5.46	8.49	6.44	7.28	4.78	5.74	5.04	4.89	4.90	4.26	3.97	3.10	3.20	3.40	2.96	3.05	NA	NA	2.92	NA
Accrued Liabilities Current		270.93	292.96	264.79	231.93	201.20	210.12	204.12	173.19	155.02	159.29	158.21	145.85	123.61	134.37	117.00	102.95	107.00	109.25	102.53	93.60	82.25	87.49	80.33	72.92	63.58	23.67	20.09	16.39	14.08	24.42	21.41	NA	NA	20.11	NA
Other Liabilities Current		44.62	40.44	35.95	41.35	62.54	47.55	30.88	25.90	31.75	27.61	30.07	21.22	24.54	23.53	22.91	24.80	25.10	18.99	21.64	14.33	18.43	4.86	4.79	5.93	8.11	4.70	5.25	3.13	5.26	3.28	4.76	NA	NA	7.53	NA
Contract With Customer Liability Current		616.70	559.86	518.75	490.56	466.04	462.73	417.93	401.37	367.22	344.64	303.85	282.22	277.81	255.66	202.61	195.35	189.56	192.36	169.53	165.45	150.24	147.94	133.40	120.94	NA	73.76	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Deferred Income Tax Liabilities Net		2.36	2.40	1.13	1.10	1.09	1.07	0.91	1.00	1.05	1.08	17.60	16.24	14.88	13.55	19.86	15.34	NA	12.85	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Other Liabilities Noncurrent		29.08	28.22	23.12	22.95	22.79	22.70	17.56	17.26	17.22	17.75	16.06	16.13	16.11	16.09	15.59	15.76	15.77	15.72	14.33	14.40	14.62	12.80	11.01	10.68	10.44	10.74	8.54	8.34	8.09	7.97	5.25	NA	NA	7.29	NA
Operating Lease Liability Noncurrent		136.16	142.12	143.04	139.39	142.69	138.87	139.20	134.98	141.62	130.97	128.21	112.85	114.14	115.14	110.67	114.98	51.40	45.21	46.02	43.73	46.24	0.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Stockholders Equity		671.54	558.95	470.91	391.06	347.26	386.39	349.88	283.25	605.02	952.93	898.09	851.88	858.93	805.78	791.63	738.07	717.80	726.28	692.01	658.05	621.90	589.70	561.39	540.08	511.07	503.53	550.25	607.36	620.98	610.71	610.54	NA	NA	413.47	NA
Common Stock Value		0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.34	0.36	0.36	0.36	0.36	0.35	0.36	0.35	0.35	0.36	0.36	0.36	0.36	0.36	0.36	0.36	0.35	0.35	0.38	0.40	0.41	0.41	0.41	NA	NA	0.33	NA
Additional Paid In Capital Common Stock		814.65	802.68	795.99	785.29	778.69	770.79	759.99	753.30	746.12	727.86	721.60	716.55	707.88	695.90	687.62	676.62	673.37	666.59	663.04	651.78	643.50	639.38	636.54	634.47	632.37	630.34	628.56	627.41	625.30	623.63	NA	NA	NA	NA	NA
Retained Earnings Accumulated Deficit		-119.14	-221.65	-300.20	-371.02	-408.10	-359.83	-380.12	-446.14	-120.81	234.98	184.95	142.31	158.53	115.23	111.81	70.35	53.83	68.11	38.30	14.32	-13.14	-41.49	-67.29	-86.60	-115.52	-120.40	-77.42	-18.42	-1.58	-9.58	-9.56	NA	NA	-23.01	NA
Accumulated Other Comprehensive Income Loss Net Of Tax		-12.04	-10.07	-12.87	-11.19	-11.31	-12.39	-16.05	-9.97	-6.39	-4.85	-3.24	-1.76	-2.27	-0.13	-2.12	-3.22	-3.73	-2.74	-3.66	-2.38	-2.79	-2.52	-2.18	-2.12	-0.10	-0.73	-1.26	-2.03	-3.15	-3.74	-2.38	NA	NA	-2.56	NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value		4.31	NA	5.01	4.91	5.44	NA	5.79	5.65	4.37	NA	4.05	3.57	2.87	NA	2.76	2.62	5.45	NA	9.47	5.38	3.18	NA	1.43	1.49	1.47	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Net Cash Provided By Used In Operating Activities		152.68	156.40	114.39	82.52	80.08	136.68	108.49	96.62	46.26	70.89	72.35	62.76	57.32	105.50	59.76	44.27	49.15	56.94	64.29	46.63	34.01	39.44	52.50	41.34	23.30	28.65	39.00	NA	NA	NA	NA	NA	NA	NA	NA
Net Cash Provided By Used In Investing Activities		2.53	-8.00	-8.66	-8.47	-9.50	-9.22	-7.19	-11.13	-11.21	-9.12	-6.60	-6.00	-9.65	-7.73	-8.64	-9.31	-5.52	-5.73	-6.13	-3.44	-3.84	-4.21	-2.79	-6.04	-3.93	-3.38	-2.35	NA	NA	NA	NA	NA	NA	NA	NA
Net Cash Provided By Used In Financing Activities		7.66	1.52	-49.27	-82.21	-52.68	-131.12	-109.11	-123.46	-412.08	2.43	-5.21	-50.78	9.10	-40.21	6.78	-8.41	-40.45	0.83	1.79	-53.52	-23.03	-33.85	-49.75	-33.98	-24.01	-23.23	-42.14	NA	NA	NA	NA	NA	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Net Cash Provided By Used In Operating Activities		152.68	156.40	114.39	82.52	80.08	136.68	108.49	96.62	46.26	70.89	72.35	62.76	57.32	105.50	59.76	44.27	49.15	56.94	64.29	46.63	34.01	39.44	52.50	41.34	23.30	28.65	39.00	NA	NA	NA	NA	NA	NA	NA	NA
Net Income Loss		102.59	78.30	70.55	61.07	72.89	68.67	66.03	49.36	61.31	50.03	48.57	39.93	43.31	50.87	41.46	24.10	28.95	29.81	23.98	27.45	19.20	22.76	19.30	16.57	14.55	11.29	9.83	9.55	8.45	-0.02	5.04	4.96	3.45	-8.58	-0.13
Increase Decrease In Other Operating Capital Net		-5.86	-4.05	5.93	22.70	-14.98	-21.57	-5.22	6.22	-1.49	3.54	-8.30	4.89	0.42	-0.88	1.30	1.05	-3.44	5.45	-7.81	6.01	-5.77	-2.53	1.17	2.52	-3.09	-1.72	-1.25	2.08	-1.88	-1.53	0.18	2.76	-0.57	-2.24	NA
Increase Decrease In Accounts Payable		-7.35	1.97	-3.26	-2.12	4.46	5.66	-1.78	3.59	-1.04	-0.28	2.42	2.37	-2.64	3.01	1.56	-0.36	-6.81	1.91	-2.52	8.02	-2.68	2.67	-2.70	0.68	0.70	5.28	2.39	-1.52	-1.33	1.63	1.17	-0.09	-2.03	1.64	NA
Deferred Income Tax Expense Benefit		-0.86	-13.81	-7.60	-2.65	-1.06	-20.89	-0.69	-0.73	-0.71	-40.41	0.63	1.38	1.29	-6.38	4.50	1.34	1.08	7.21	1.00	1.18	0.66	-3.32	7.55	-0.04	-0.25	3.66	0.44	-0.45	-0.41	-8.44	-0.09	-0.17	-0.31	-4.38	NA
Share Based Compensation		4.31	5.17	5.01	4.91	5.44	5.59	5.79	5.65	4.37	3.98	4.05	3.57	2.87	2.96	2.76	2.62	5.45	2.71	9.47	5.38	3.18	2.11	1.43	1.49	1.47	1.25	0.98	1.20	1.03	1.26	4.28	3.27	1.01	10.49	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Net Cash Provided By Used In Investing Activities		2.53	-8.00	-8.66	-8.47	-9.50	-9.22	-7.19	-11.13	-11.21	-9.12	-6.60	-6.00	-9.65	-7.73	-8.64	-9.31	-5.52	-5.73	-6.13	-3.44	-3.84	-4.21	-2.79	-6.04	-3.93	-3.38	-2.35	NA	NA	NA	NA	NA	NA	NA	NA
Payments To Acquire Property Plant And Equipment		5.50	9.99	8.70	8.45	9.51	9.24	7.18	11.20	9.26	9.12	6.64	6.01	6.51	7.79	8.67	9.32	5.56	5.76	6.16	3.47	2.52	3.45	2.78	5.84	3.95	3.40	2.31	1.65	4.37	5.69	2.15	2.24	3.46	1.78	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Net Cash Provided By Used In Financing Activities		7.66	1.52	-49.27	-82.21	-52.68	-131.12	-109.11	-123.46	-412.08	2.43	-5.21	-50.78	9.10	-40.21	6.78	-8.41	-40.45	0.83	1.79	-53.52	-23.03	-33.85	-49.75	-33.98	-24.01	-23.23	-42.14	NA	NA	NA	NA	NA	NA	NA	NA
Payments For Repurchase Of Common Stock		NA	0.00	0.00	23.87	120.15	47.18	0.00	374.72	425.95	0.00	6.22	NA	NA	47.45	0.00	9.05	41.78	NA	NA	0.00	0.00	0.00	0.00	NA	NA	60.32	68.86	26.40	NA	0.00	0.00	NA	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Revenues		511.04	498.40	492.50	460.87	434.07	394.10	383.74	351.21	330.95	308.55	295.57	278.29	259.96	259.68	230.37	205.00	230.88	229.89	216.24	214.10	200.74	192.12	179.25	170.14	163.08	112.68	110.64	106.22	0.00	108.24	107.80	105.95	99.59	96.04	92.13
Revenue From Contract With Customer Excluding Assessed Tax		511.04	498.40	492.50	460.87	434.07	394.10	383.74	351.21	330.95	308.55	295.57	278.29	259.96	259.68	230.37	205.00	230.88	229.89	216.24	214.10	200.74	192.12	179.25	170.14	163.08	112.68	110.64	106.22	106.61	108.24	107.80	105.95	99.59	96.04	92.13
Cin Rx Pharma And Subsidiaries, Revenue Net, Related Party Service Agreement, Related Party		NA	4.40	5.30	3.60	NA	1.20	0.50	7.50	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
L I B Therapeutics L L C And Subsidiaries, Revenue Net, Related Party Service Agreement, Related Party		NA	10.60	10.10	9.70	NA	13.90	9.50	9.70	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Cin Rx Pharma And Subsidiaries, Related Party Service Agreement, Related Party		6.30	NA	NA	NA	2.50	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
L I B Therapeutics L L C And Subsidiaries, Related Party Service Agreement, Related Party		6.50	NA	NA	NA	13.30	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Antiviral And Anti Infective		44.03	48.89	45.55	36.01	32.87	29.69	31.45	25.58	31.32	26.93	27.03	26.19	30.82	27.88	27.24	22.99	25.15	19.56	24.24	22.66	19.92	17.78	22.10	20.19	16.68	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Cardiology		55.64	51.58	44.36	51.13	46.62	45.41	49.80	42.03	37.40	33.15	34.74	28.04	23.76	19.91	27.59	21.75	25.90	22.47	21.73	22.14	20.42	22.52	21.06	24.51	23.74	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Central Nervous System		44.14	39.65	43.99	37.73	38.70	37.13	43.42	38.91	38.49	35.33	32.85	28.55	24.81	23.45	21.75	19.22	23.98	17.05	16.33	16.79	14.87	13.80	13.83	13.11	13.16	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Metabolic		103.64	99.02	103.12	87.86	86.84	77.49	63.48	55.60	48.12	47.13	42.13	38.14	32.49	30.17	29.62	30.21	36.08	36.36	34.92	31.49	33.74	26.25	22.93	22.89	22.05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Oncology		155.20	148.73	149.33	147.09	141.95	124.21	122.83	115.54	105.21	95.74	94.72	93.25	79.14	94.20	68.63	65.63	69.21	70.61	65.53	64.62	55.96	53.23	48.94	43.00	43.85	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Other		108.40	110.53	106.16	101.06	87.10	80.17	72.77	73.56	70.42	70.27	64.09	64.12	68.94	64.06	55.54	45.20	50.57	63.84	53.48	51.94	51.32	48.45	41.46	37.06	34.22	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Revenue Net		NA	498.40	492.50	460.87	434.07	394.10	383.74	351.21	330.95	308.55	295.57	278.29	259.96	259.68	230.37	205.00	230.88	229.89	216.24	214.10	200.74	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Related Party		12.80	15.00	15.50	13.30	15.80	15.10	9.80	17.20	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

Plots across concepts

Line plots across dimensions of each concept